论文部分内容阅读
1991年1月～1993年12月,我科对50例中深度高胆红素血症病毒性肝炎,用654-2静脉输注加20％甘露醇口服治疗,与对照组比较其疗效明显优于对照组。报告如下: 1 临床资料 病例选择:全部病例系住院病人,均符合1984年南宁会议诊断标准,确诊为急性黄疽型病毒性肝炎,对血清总胆红素中度以上100例(总胆红素在64.6～227.4umol/L)随机抽样分两组治疗组50例,男46人,女4人:年龄18～49岁,平均年龄31.5岁;平均血清总胆红素136.5umol/L,谷丙转氨酶(SGPT)平均146单位,对照组50人,男38人,女12人:年龄17～51岁,平均年龄33岁,平均血清总胆红素139.7umol/L,谷丙转氨酶(SGPT)平均132单位,检查SGPT用赖氏法(正常
January 1991 ~ December 1993, our department of 50 cases of moderate hyperbilirubinemia viral hepatitis, with 654-2 intravenous infusion of 20% mannitol oral treatment, compared with the control group was significantly better In the control group. The report is as follows: 1 Clinical data Case selection: all cases in-patient patients, are in line with the diagnostic criteria of Nanning Conference in 1984, was diagnosed as acute yellow ganglion-type hepatitis, serum total bilirubin more than 100 moderate (total bilirubin In 64.6 ~ 227.4umol / L) were randomly divided into two treatment groups of 50 patients, 46 males and 4 females: aged 18 to 49 years, mean age 31.5 years; mean serum total bilirubin 136.5umol / L, Average 146 units of transaminase (SGPT), control group of 50 people, 38 males and 12 females: aged 17 to 51 years, mean age 33 years, mean serum total bilirubin 139.7umol / L, alanine aminotransferase (SGPT) 132 units, check SGPT with Lai’s method (normal